Feature | January 12, 2012

January 12, 2012 — An article in the January issue of the Journal of the American College of Radiology summarizes methods for radiation dose optimization in pediatric computed tomography (CT) scans. Approximately seven to eight million CT examinations are performed for various pediatric clinical indications per year in the United States.


Justification of clinical indication is the most important aspect of reducing radiation dose with CT scanning. A substantial number of pediatric CT scans lack appropriate justification or can be replaced with other imaging modalities with lower or no ionizing radiation, such as radiography, ultrasonography and magnetic resonance imaging (MRI), which can provide similar diagnostic information for some clinical conditions. 


“When not clinically indicated, not performing a CT examination is certainly the best radiation dose reduction strategy. However, when a CT scan is indicated, there are steps that can be taken to optimize the dose that children receive. It’s important that all imaging providers take these steps as indicated,” said Mannudeep K. Kalra, M.D., author of the article. 


Investigators from Massachusetts General Hospital, Harvard Medical School, in Boston, and Johns Hopkins University in Baltimore, reviewed practical strategies for reducing radiation dose associated with pediatric CT examinations. “Radiation dose reduction in children starts with the optimization of pediatric CT protocols,” said Mahadevappa Mahesh, MS, Ph.D., author of the article. “CT protocols should be strictly optimized on the basis of body size, body region, clinical indication and the availability of prior imaging.”


Additional steps include using a lower tube current and voltage, restricting the scan length to include only the region of interest and using new techniques of image post-processing and reconstruction.   


“Children are more sensitive to radiation-induced risks and need special attention. Therefore, while designing CT protocols, it is crucial to keep clinical indications, weight and prior available imaging in mind to optimize radiation dose,” said Mahesh.


 For more information: www.jacr.org, www.imagewisely.org, www.imagegently.org


Related Content

Navidea, Mass General, Tc99m-tilmanocept, vulnerable plaque, cardiovascular disease, Harvard
News | Radiopharmaceuticals and Tracers| July 30, 2015
Navidea Biopharmaceuticals Inc. announced plans to move forward with a joint study of the ability of Tc99m-tilmanocept...
MSCs, stem cells, end-stageheart failure, retrograde, coronary sinus,
News | Stem Cell Therapies| July 29, 2015
A new clinical trial to test how a high dose of stem cells delivered via a method called retrograde coronary sinus...
Guerbet, acquisition, Mallinckrodt, CMDS business, contrast media, CT, MRI
News | Contrast Media| July 29, 2015
Guerbet announced that it has entered into a definitive agreement under which it will acquire Mallinckrodt's contrast...
heart failure, Adaptive CRT trial, AdaptivCRT algorithm, readmissions
News | Heart Failure| July 22, 2015
Heart failure patients had a significantly lower chance of being readmitted within 30 days of discharge when treated...
Direct Flow Medical, Transcatheter Aortic Valve System, SALUS Trial, FDA
News | Heart Valve Repair| July 22, 2015
Direct Flow Medical Inc. received Investigational Device Exemption (IDE) approval from the U.S. Food and Drug...
Xarelto, anticoagulant protocol, discharge, outcomes, DVT, PE
News | Antiplatelet and Anticoagulation Therapies| July 21, 2015
Two companion papers published in Academic Emergency Medicine  address the question of when it is appropriate to...
UNC, biomarkers, severe heart disease, fructosamine, LDL cholesterol, Nichols
News | Cardiac Diagnostics| July 21, 2015
Insulin resistance affects tens of millions of Americans and is a big risk factor for heart disease. Yet, some people...
Feature | Atrial Fibrillation| July 20, 2015
A new study proves race and gender-related disparities exist in care for patients who have recently been diagnosed with...
Boston Scientific, fully absorbable scaffold, FAST study, resorbable
Feature | Stents Bioresorbable| July 20, 2015
Boston Scientific has initiated a study of the company's first fully resorbable drug-eluting scaffold system. The Fully...
Veryan Medical, BioMimics 3D femoropopliteal stent, MIMICS-2 study, PAD
News | Stents Peripheral| July 17, 2015
Veryan Medical announced that the first subject has been enrolled in their MIMICS-2 study at Universitäts-Herzzentrum...
Overlay Init